Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 1985
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Adenocarcinoma (MeSH)
- Adult (MeSH)
- Aged (MeSH)
- Anthracenes (MeSH)
- Antibiotics, Antineoplastic (MeSH)
- Drug Evaluation (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Kidney Neoplasms (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Phlebitis (MeSH)